為了探討臺灣產桑科植物天仙果(Ficus formosana Maxium. f. formosana)對人類肝癌、血癌和淋巴癌細胞株活性成分,先後對其莖部的正己烷可溶部和氯仿可溶部進行活性成分分離,共得到20個化合物,包括三個chromene類:alloptaeroxylin (1)、ficuformodiol A (2)、ficuformodiol B (3);五個flavonoid類:carpachromene (4)、5-hydroxy-8,8-dimethy-2-phenyl-8H-pyrano[3,2-g]chromen-4-one (5)、apigenin (6)、steppogenin (7)、glabranin (8);一個cinnamic acid類:chromenylacrylic acid (9);一個isocoumarin類:(R)-(-)-mellein (10);四個triterpenoid類:squalene (11)、taraxeryl acetate (12)、bauera-7,9(11)-dien-3b-yl acetate (13)、oleana-11:13(18)-dien-3b-yl acetate (14);六個steroid類:b-sitosterol (15) 和stigmasterol (16) 的混合物、 b-sitostenone (17)和stigmasta-4,22-dien-3-one (18) 的混合物、b-sitosterol-3-O-b-D-glucoside (19) 和b-stigmasterol-3-O-b-D- glucoside (20)的混合物。這些化合物均由光譜分析來決定其構造式。 其中,化合物2及3為天然首次分離之新化合物。將分離的化合物對人類四種癌細胞株包括未帶有B型肝炎病毒[HBV Ag (-)]的人類肝癌細胞株(HepG2)、帶有B型肝炎病毒[HBV Ag (+)]的人類肝癌細胞株(PLC/PRF/5)、血癌(THP-1)和淋巴癌(Raji)細胞株進行細胞毒體外活性試驗,結果發現化合物4和6對人類肝癌細胞株(HepG2和PLC/PRF/5)和淋巴癌細胞株(Raji)具有毒殺作用。
The cytotoxic constituents against hepatoma, leukemia and lymphoma cancer cell lines in vitro were performed the studies on the stems of Ficus formosana Maxium. f. formosana (Moraceae). Investigation of the n-hexane- and CHCl3-soluble layers led to the isolation of 20 compounds, including three chromenes: alloptaeroxylin (1), ficuformodiol A (2), ficuformodiol B (3); five flavonoids: carpachromene (4), 5-hydroxy-8,8-dimethy-2-phenyl-8H-pyrano- [3,2-g]chromen-4-one (5), apigenin (6), steppogenin (7), glabranin (8); one cinnamic acid: chromenylacrylic acid (9); one isocoumarin: (R)-(-)-mellein (10); four triterpenoids: squalene (11), taraxeryl acetate (12), bauera-7,9(11)-dien-3b-yl acetate (13), oleana-11:13(18)-dien- 3b-yl acetate (14); six steroids: the mixture of b-sitosterol (15) and stigmasterol (16), the mixture of b-sitostenone (17) and stigmasta- 4,22-dien-3-one (18), the mixture of b-sitosterol-3-O-b-D-glucoside (19) and b-stigmasterol-3-O-b-D-glucoside (20). The structures of these compounds were determined by spectroscopic analysis. Among these isolates, 2 and 3 are new compounds from the nature. These isolates were screened their cytotoxicities against HepG2 [human hepatoma: HBV Ag (-)], PLC/PRF/5 [human hepatoma: HBV Ag (+)], THP-1 (acute monocytic leukemia) and Raji (lymphoma) cancer cell lines in vitro. Compounds 4 and 6 exhibited cytotoxicity against HepG2, PLC/PRF/5 and Raji cancer cell lines.